Physician profile
Thomas Martin
NPI 1114169570
$29,743.42
in general payments reported to CMS, 2019-2025
13 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,243 · 2020: $1,261 · 2021: $13K · 2022: $3,457 · 2023: $711 · 2024: $449 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568 · Travel and Lodging: $939 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.16 |
| Travel and Lodging | $938.87 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,066.81 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,174.16 | 2022 | |
| Davol INC. | $1,024.15 | 2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $576.55 | 2019-2024 | Gore Synecor Biomaterial |
| Novo Nordisk INC | $255.11 | 2021-2022 | |
| Teleflex LLC | $140.78 | 2024 | Titan Sgs |
| Medtronic, INC. | $137.02 | 2025 | Progrip |
| Baxter Healthcare | $117.80 | 2019 | |
| Allergan, INC. | $115.38 | 2021 | |
| Apollo Endosurgery US INC | $79.75 | 2022 | |
| Innocoll Pharmaceuticals Limited | $20.14 | 2022 | |
| Lilly USA, LLC | $19.38 | 2024 | Zepbound |
| Depuy Synthes Sales INC. | $16.39 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.